Legal Representation
Attorney
Frank W. Compagni
USPTO Deadlines
Next Deadline
552 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-26)
Due Date
January 26, 2027
Grace Period Ends
July 26, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 7, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
May 15, 2021 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Apr 30, 2021 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
Apr 29, 2021 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
Apr 26, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jan 26, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 10, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 10, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 8, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Oct 21, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 21, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Oct 21, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Oct 6, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Oct 6, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 6, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 6, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 6, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 25, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 24, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 24, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 10, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Mar 24, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Mar 24, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Mar 4, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Mar 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 25, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 14, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Jan 8, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 2, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005